Iida, Miho

J-GLOBAL         Last updated: May 29, 2019 at 04:27
 
Avatar
Name
Iida, Miho
Affiliation
Keio University
Section
School of Medicine Department of Preventive Medicine and Public Health
Job title
Instructor
Other affiliation
School of Medicine
Research funding number
70594505

Research Areas

 
 

Academic & Professional Experience

 
Apr 2008
 - 
Mar 2010
初期研修医, 亀田総合病院
 
Apr 2010
 - 
Mar 2014
専修医, 産婦人科学教室, 慶應義塾大学医学部
 
Apr 2011
 - 
Mar 2012
専攻医, 産婦人科, 済生会宇都宮病院
 
Apr 2012
 - 
Mar 2013
専攻医, 産婦人科, 川崎市立川崎病院
 
Oct 2017
 - 
Mar 2018
助教, 産婦人科学教室, 慶應義塾大学医学部
 

Education

 
Apr 2002
 - 
Mar 2008
医学科, 医学部, 慶應義塾大学
 
Apr 2014
 - 
Sep 2017
博士課程, 医学研究科, 慶應義塾大学
 

Committee Memberships

 
Sep 2018
 - 
Today
慶應義塾大学病院食養委員会  食養委員
 

Awards & Honors

 
Apr 2017
閉経後女性におけるメタボリック症候群の血漿メタボローム・プロファイリング, 2017 JSOG Best Paper Award (Women's Health section), Japan Society of Obstetrics and Gynecology (JSOG)
 
Apr 2017
閉経後女性におけるメタボリック症候群の血漿メタボローム・プロファイリング, 2017 JSOG Best Paper Award (Women's Health section), Japan Society of Obstetrics and Gynecology (JSOG)
 
Nov 2015
閉経後女性におけるメタボリック症候群の血漿メタボローム解析:鶴岡メタボロームコホート研究, The 30th annual meeting of the Japan Society for Menopause and Women’s Health Best Presentation Award, Japan Society for Menopause and Women’s Health (JMWH)
 
Nov 2015
閉経後女性におけるメタボリック症候群の血漿メタボローム解析:鶴岡メタボロームコホート研究, The 30th annual meeting of the Japan Society for Menopause and Women’s Health Best Presentation Award, Japan Society for Menopause and Women’s Health (JMWH)
 
Mar 2010
鉄蕉会亀田総合病院 22期 The Best Resident賞
 

Published Papers

 
IIDA Miho, Harada S, Kurihara A, Fukai K, Kuwabara K, Sugiyama D, Takeuchi A, Okamura T, Akiyama M, Nishiwaki Y, Suzuki A, Hirayama A, Sugimoto M, Soga T, Tomita M, Banno K, Aoki D, Takebayashi T.
Menopause.   23(7) 749-758   Jul 2016   [Refereed]
OBJECTIVE:The aim of the study was to investigate the associations of amino acids and other polar metabolites with metabolic syndrome (MetS) in postmenopausal women in a lean Asian population.

METHODS:The participants were 1,422 female residents ...
Metabolic Profiling of Total Physical Activity and Sedentary Behavior in Community-Dwelling Men.
Fukai K, Harada S, IIDA Miho, Kurihara A, Takeuchi A, Kuwabara K, Sugiyama D, Okamura T, Akiyama M, Nishiwaki Y, Oguma Y, Suzuki A, Suzuki C, Hirayama A, Sugimoto M, Soga T, Tomita M, Takebayashi T.
PLoS One.   14(11 (10)) e0164877   Oct 2016   [Refereed]
Harada S, Hirayama A, Chan Q, Kurihara A, Fukai K, .Iida M, Kato S, Sugiyama D, Kuwabara K, Takeuchi A, Akiyama M, Okamura T, Ebbels TMD, Elliott P, Tomita M, Sato A, Suzuki C, Sugimoto M, Soga T, Takebayashi T
PLoS One   13(1) e0191230   Jan 2018   [Refereed]
© 2018 Harada et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are ...
Okawa, R., Banno, K., Iida, M., Yanokura, M., Takeda, T., Iijima, M., Kunitomi-Irie, H., Nakamura, K., Adachi, M., Umene, K., Nogami, Y., Masuda, K., Kobayashi, Y., Tominaga, E. and Aoki, D.
Oncol Lett   14(5) 5107-5113   Nov 2017
Epigenetic regulatory mechanisms are a current focus in studies investigating cancer. Chromatin remodeling alters chromatin structure and regulates gene expression, and aberrant chromatin remodeling is involved in carcinogenesis. AT-rich interacti...
Kobayashi, Y., Kashima, H., Rahmanto, Y. S., Banno, K., Yu, Y., Matoba, Y., Watanabe, K., Iijima, M., Takeda, T., Kunitomi, H., Iida, M., Adachi, M., Nakamura, K., Tsuji, K., Masuda, K., Nomura, H., Tominaga, E. and Aoki, D.
Oncotarget   8(42) 72147-72156   Sep 2017
Drug repositioning is an alternative strategy redirecting existing drugs for new disease. We have previously reported an antitumor effect of statins, antidyslipidemic drugs, on ovarian cancer in vitro and in vivo. In this study, we investigated th...
Kunitomi, H., Banno, K., Yanokura, M., Takeda, T., Iijima, M., Nakamura, K., Iida, M., Adachi, M., Watanabe, K., Matoba, Y., Kobayashi, Y., Tominaga, E. and Aoki, D.
Oncol Lett   14(3) 3297-3301   Sep 2017
The increasing incidence of obesity and diabetes due to changes in diet, earlier menarche, delayed menopause, late marriage, and declining birth rate have resulted in an increase in the number of endometrial cancer cases over the last few decades....
Iijima, M., Banno, K., Okawa, R., Yanokura, M., Iida, M., Takeda, T., Kunitomi-Irie, H., Adachi, M., Nakamura, K., Umene, K., Nogami, Y., Masuda, K., Tominaga, E. and Aoki, D.
Oncol Lett   13(3) 1063-1070   Mar 2017
Cancer typically develops due to genetic abnormalities, but a single gene abnormality cannot completely account for the onset of cancer. The Cancer Genome Atlas (CGA) project was conducted for the cross-sectional genome-wide analysis of numerous g...
Methylation Analysis of DNA Mismatch Repair Genes Using DNA Derived from the Peripheral Blood of Patients with Endometrial Cancer: Epimutation in Endometrial Carcinogenesis.
Takeda T, Banno K, Yanokura M, Adachi M, Iijima M, Kunitomi H, Nakamura K, IIDA Miho, Nogami Y, Umene K, Masuda K, Kobayashi Y, Yamagami W, Hirasawa A, Tominaga E, Susumu N, Aoki D.
Genes (Basel).   14(7(10)) E86   Jul 2016   [Refereed]
Takeda, T., Banno, K., Okawa, R., Yanokura, M., Iijima, M., Irie-Kunitomi, H., Nakamura, K., Iida, M., Adachi, M., Umene, K., Nogami, Y., Masuda, K., Kobayashi, Y., Tominaga, E. and Aoki, D.
Oncol Rep   35(2) 607-13   Feb 2016
The AT-rich interacting domaincontaining protein 1A gene (ARID1A) encodes ARID1A, a member of the SWI/SNF chromatin remodeling complex. Mutation of ARID1A induces changes in expression of multiple genes (CDKN1A, SMAD3, MLH1 and PIK3IP1) via chroma...
Irie, H., Banno, K., Yanokura, M., Iida, M., Adachi, M., Nakamura, K., Umene, K., Nogami, Y., Masuda, K., Kobayashi, Y., Tominaga, E. and Aoki, D.
Oncol Lett   11(2) 1287-1293   Feb 2016
Metformin is a first-line drug used for the treatment of type 2 diabetes. Recently, metformin has been reported to reduce the carcinogenic risk and inhibit tumor cell growth in glioma and breast cancer. The anticancer action of metformin involves ...
ARID1A gene mutation in ovarian and endometrial cancers (Review).
Takeda T, Banno K, Okawa R, Yanokura M, Iijima M, Irie-Kunitomi H, Nakamura K, IIDA Miho, Adachi M, Umene K, Nogami Y, Masuda K, Kobayashi Y, Tominaga E, Aoki D.
Oncology Reports   35(2) 607-613   Feb 2016   [Refereed]
Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning.
Irie H, Banno K, Yanokura M, IIDA Miho, Adachi M, Nakamura K, Umene K, Nogami Y, Masuda K, Kobayashi Y, Tominaga E, Aoki D.
Oncology Letters.   11(2) 1287-1293   Feb 2016   [Refereed]
Fukai, K., Harada, S., Iida, M., Kurihara, A., Takeuchi, A., Kuwabara, K., Sugiyama, D., Okamura, T., Akiyama, M., Nishiwaki, Y., Oguma, Y., Suzuki, A., Suzuki, C., Hirayama, A., Sugimoto, M., Soga, T., Tomita, M. and Takebayashi, T.
PLoS One   11(10) e0164877   2016
OBJECTIVE: Physical activity is known to be preventive against various non-communicable diseases. We investigated the relationship between daily physical activity level and plasma metabolites using a targeted metabolomics approach in a population-...
Umene, K., Yanokura, M., Banno, K., Irie, H., Adachi, M., Iida, M., Nakamura, K., Nogami, Y., Masuda, K., Kobayashi, Y., Tominaga, E. and Aoki, D.
Int J Oncol   46(4) 1498-506   Apr 2015
Aurora kinase A (AURKA) regulates the cell cycle checkpoint and maintains genomic integrity. AURKA is overexpressed in various malignant tumors and its upregulation induces chromosomal instability, which leads to aneuploidy and cell transformation...
Nogami, Y., Banno, K., Irie, H., Iida, M., Masugi, Y., Murakami, K. and Aoki, D.
Anticancer Res   35(4) 2247-53   Apr 2015
AIM: This study investigated whether dual-phase scanning (DPS) with 18-fludeoxyglucose positron emission tomography -computed tomography (FDG PET-CT) improves diagnosis of lymph node metastasis (LNM) in gynecologic malignancies, compared to mono-p...
Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancer.
Umene K, Yanokura M, Banno K, Irie H, Adachi M, IIDA Miho, Nakamura K, Nogami Y, Masuda K, Kobayashi Y, Tominaga E, Aoki D.
International Journal of Oncology   46(4) 1498-1506   Apr 2015
Efficacy of 18-FDG PET-CT Dual-phase Scanning for Detection of Lymph Node Metastasis in Gynecological Cancer.
Nogami Y, Banno K, Irie H, IIDA Miho, Masugi Y, Murakami K, Aoki D.
Anticancer Research   35(4) 2247-2253   Apr 2015
Kobayashi, Y., Nakamura, K., Nomura, H., Banno, K., Irie, H., Adachi, M., Iida, M., Umene, K., Nogami, Y., Masuda, K., Kisu, I., Ueki, A., Yamagami, W., Kataoka, F., Hirasawa, A., Tominaga, E., Susumu, N. and Aoki, D.
Int J Gynecol Cancer   25(3) 440-6   Mar 2015
OBJECTIVE: Synchronous primary endometrial and ovarian cancers have been an important topic in clinical medicine because it is sometimes difficult to distinguish whether there are 2 primary tumors or a single primary tumor and an associated metast...
Adachi, M., Banno, K., Yanokura, M., Iida, M., Nakamura, K., Nogami, Y., Umene, K., Masuda, K., Kisu, I., Ueki, A., Hirasawa, A., Tominaga, E. and Aoki, D.
Mol Clin Oncol   3(2) 267-273   Mar 2015
Risk-reducing surgery (RRS) is defined as a prophylactic approach with removal of organs at high risk of developing cancer, which is performed in cases without lesions or absence of clinically significant lesions. Hereditary gynecological cancers ...
Clinicopathologic analysis with immunohistochemistry for DNA mismatch repair protein expression in synchronous primary endometrial and ovarian cancers.
Kobayashi Y, Nakamura K, Nomura H, Banno K, Irie H, Adachi M, IIDA Miho, Umene K, Nogami Y, Masuda K, Kisu I, Ueki A, Yamagami W, Kataoka F, Hirasawa A, Tominaga E, Susumu N, Aoki D.
Int J Gynecol Cancer   25(3) 440-446   Mar 2015
Drug Repositioning for Gynecologic Tumors: A New Therapeutic Strategy for Cancer.
Banno K, IIDA Miho, Yanokura M, Irie H, Masuda K, Kobayashi Y, Tominaga E, Aoki D.
The Scientific World Journal   2015(2015) 341362   Feb 2015
MicroRNAS in endometrial cancer: recent advances and potential clinical applications.
Yanokura M, Banno K, Iida M, Irie H, Umene K, IIDA Miho, Masuda K, Kobayashi Y, Tominaga E, Aoki D.
EXCLI Journal   14 190-198   Feb 2015
Nogami, Y., Banno, K., Irie, H., Iida, M., Kisu, I., Masugi, Y., Tanaka, K., Tominaga, E., Okuda, S., Murakami, K. and Aoki, D.
Jpn J Clin Oncol   45(1) 26-34   Jan 2015
OBJECTIVE: We studied the diagnostic performance of (18)F-fluoro-2-deoxy-d-glucose-positron emission tomography/computed tomography in cervical and endometrial cancers with particular focus on lymph node metastases. METHODS: Seventy patients with ...
The efficacy of preoperative positron emission tomography-computed tomography (PET-CT) for detection of lymph node metastasis in cervical and endometrial cancer: clinical and pathological factors influencing it.
Nogami Y, Banno K, Irie H, IIDA Miho, Masugi Y, Tanaka K, Tominaga E, Okuda S, Murakami K, Aoki D.
Japanese Journal of Clinical Oncology   45(1) 26-34   Jan 2015
Yanokura, M., Banno, K., Iida, M., Irie, H., Umene, K., Masuda, K., Kobayashi, Y., Tominaga, E. and Aoki, D.
EXCLI J   14 190-8   2015
Endometrial cancer is a common malignant gynecological tumor, but there are few biomarkers that are useful for early and accurate diagnosis and few treatments other than surgery. However, use of microRNAs (miRNAs) that induces gene downregulation ...
Banno, K., Iida, M., Yanokura, M., Irie, H., Masuda, K., Kobayashi, Y., Tominaga, E. and Aoki, D.
ScientificWorldJournal   2015 341362   2015
The goals of drug repositioning are to find a new pharmacological effect of a drug for which human safety and pharmacokinetics are established and to expand the therapeutic range of the drug to another disease. Such drug discovery can be performed...
Risk-reducing surgery in hereditary gynecological cancer: Clinical applications in Lynch syndrome and hereditary breast and ovarian cancer.
Adachi M, Banno K, Yanokura M, IIDA Miho, Nakamura K, Nogami Y, Umene K, Masuda K, Kisu I, Ueki A, Hirasawa A, Tominaga E, Aoki D.
Molecular and Clinical Oncology   3(2) 267-273   2015
Nakamura, K., Banno, K., Yanokura, M., Iida, M., Adachi, M., Masuda, K., Ueki, A., Kobayashi, Y., Nomura, H., Hirasawa, A., Tominaga, E. and Aoki, D.
Mol Clin Oncol   2(6) 909-916   Nov 2014
Lynch syndrome is a hereditary ovarian cancer with a prevalence of 0.9-2.7%. Lynch syndrome accounts for 10-15% of hereditary ovarian cancers, while hereditary breast and ovarian cancer syndrome accounts for 65-75% of these cancers. The lifetime r...
Features of ovarian cancer in Lynch syndrome (Review).
Nakamura K, Banno K, Yanokura M, IIDA Miho, Adachi M, Masuda K, Ueki A, Kobayashi Y, Nomura H, Hirasawa A, Tominaga E, Aoki D.
Molecular and Clinical Oncology   2(6) 909-916   Nov 2014
Iida, M., Banno, K., Yanokura, M., Nakamura, K., Adachi, M., Nogami, Y., Umene, K., Masuda, K., Kisu, I., Iwata, T., Tanaka, K. and Aoki, D.
Mol Clin Oncol   2(5) 647-655   Sep 2014
Cervical cancer ranks high among the causes of female cancer mortalities and is an important disease in developing and developed countries. Current diagnosis of cervical cancer depends on colposcopy, pathological diagnosis and preoperative diagnos...
Candidate biomarkers for cervical cancer treatment: Potential for clinical practice. (Review)
IIDA Miho, Banno K, Yanokura M, Nakamura K, Adachi M, Nogami Y, Umene K, Masuda K, Kisu I, Iwata T, Tanaka K, Aoki D.
Molecular and Clinical Oncology   2(5) 647-655   Sep 2014
Banno, K., Yanokura, M., Iida, M., Masuda, K. and Aoki, D.
J Obstet Gynaecol Res   40(8) 1957-67   Aug 2014
Endometrial cancer is increasing worldwide and the number of patients with this disease is likely to continue to grow, including younger patients. Many endometrial cancers show estrogen-dependent proliferation, but the carcinogenic mechanisms are ...
Carcinogenic mechanisms of endometrial cancer: involvement of genetics and epigenetics.
Banno K, Yanokura M, IIDA Miho, Masuda K, Aoki D.
Journal of Obstetrics and Gynaecology Research   40(8) 1957-1967   Aug 2014
Application of microRNA in diagnosis and treatment of ovarian cancer.
Banno K, Yanokura M, IIDA Miho, Adachi M, Nakamura K, Nogami Y, Umene K, Masuda K, Kisu I, Nomura H, Kataoka F, Tominaga E, Aoki D.
BioMed Research International   2014(2014) 232817   Apr 2014
Nogami, Y., Iida, M., Banno, K., Kisu, I., Adachi, M., Nakamura, K., Umene, K., Masuda, K., Tominaga, E., Tanaka, K. and Aoki, D.
Anticancer Res   34(2) 585-92   Feb 2014
Positron-emission tomography (PET), a diagnostic imaging technique using an agent labeled with a positron-emitting radionuclide, may facilitate improved diagnosis and treatment in gynecological fields. A combined PET/computerized tomography (CT) s...
Application of FDG-PET in cervical cancer and endometrial cancer: utility and future prospects.
Nogami Y, IIDA Miho, Banno K, Kisu I, Adachi M, Nakamura K, Umene K, Masuda K, Tominaga E, Tanaka K, Aoki D.
Anticancer Research   34(2) 585-592   Feb 2014
MicroRNA in cervical cancer: OncomiRs and tumor suppressor miRs in diagnosis and treatment.
Banno K, IIDA Miho, Yanokura M, Kisu I, Iwata T, Tominaga E, Tanaka K, Aoki D.
The Scientific World Journal   2014(2014) 1780753   Jan 2014
Banno, K., Yanokura, M., Iida, M., Adachi, M., Nakamura, K., Nogami, Y., Umene, K., Masuda, K., Kisu, I., Nomura, H., Kataoka, F., Tominaga, E. and Aoki, D.
Biomed Res Int   2014 232817   2014
Ovarian cancer has a poor prognosis because early detection is difficult and recurrent ovarian cancer is usually drug-resistant. The morbidity and mortality of ovarian cancer are high worldwide and new methods of diagnosis and therapy are needed. ...
Banno, K., Iida, M., Yanokura, M., Kisu, I., Iwata, T., Tominaga, E., Tanaka, K. and Aoki, D.
ScientificWorldJournal   2014 178075   2014
Cervical cancer is a female-specific disease with a high incidence and mortality. MicroRNAs (miRNAs) are implicated in posttranscriptional regulation of gene expression and in the pathogenic mechanisms of cancer, suggesting their importance in dia...
Office management of lost intrauterine devices either with or without strings.
Lin BL, IIDA Miho, Suzuki T, Yabuno A, Kim S, Iwata S, Nagai Y.
Gynecology and Minimally Invasive Therapy   3(1) 15-18   Aug 2013
Removal of endometrial polyps through a small-caliber diagnostic flexible hysteroscope using a Lin polyp snare system.
Lin BL, IIDA Miho, Yabuno A, Higuchi T, Murakoshi Y, Iwata S, Zhao Y.
Gynecology and Minimally Invasive Therapy   2(1) 18-21   Jan 2013
常位胎盤早期剥離を合併した新生児先天性白血病の一例.
飯田 美穂, 梅根紀代子, 加藤恵美子, 石井博樹, 高田舞子, ヴァルクス公美子, 須藤慎介, 細川知俊, 飯田俊彦.
栃木県母性衛生学会雑誌   38 36-37   Mar 2012   [Refereed]
MRI検査で診断し,MTX化学療法と子宮動脈塞栓術により子宮温存しえた帝王切開瘢痕部妊娠の1例.
飯田 美穂, 小林佑介, 浅田弘法, 宮越 敬, 峰岸一宏, 田中 守, 青木大輔, 吉村泰典.
東京産科婦人科学会会誌   60(3) 516-520   Sep 2011   [Refereed]

Misc

 
メタボロームを用いた高血圧のコホート研究
飯田 美穂、武林 亨
血圧   26(1) 40-44   2019   [Invited]
質の高いコホート研究にメタボローム解析を適用することで、遺伝と環境の両要因を鋭敏に反映する生体内の代謝物質全体をプロファイリングすることが可能となり、バイオマーカー探索や疾患発症予測、創薬開発など様々な活用が期待されている。2008年のINTERMAP研究を皮切りに数多くのメタボロームコホート研究が行われ、血圧に関連する代謝物質やそれらを産生する腸内細菌による血圧制御機序などが報告されている。国内のコホート研究は限定的ながらも、本邦からのエビデンス創出に取り組んでいる。今後は、国内外のコホ...
IIDA Miho
治療 2018年 4月号 特集 「お母さんを守ろう -家庭医は産前家族の応援団- 」   100(4) 376-379   Mar 2018   [Invited]
妊娠中やこれから妊娠を予定している女性とその家族に,外来診療の限られた時間のなかで最適なアドバイスをするための情報が掲載されている。コモンディジーズに罹っている妊婦への対応や処方はもちろん,外来でふと聞かれたときにも対応できる不妊治療の知識や,ワクチン,生活指導のほか,産業医からの視点や健康の社会的決定要因などが分かりやすく記述されている。

Books etc

 
Banno K, IIDA Miho, Farghaly SA, Umene K, Kisu I, Aoki D (Part:Contributor, Novel Therapeutic Agents for Treatment of Endometrial Cancer)
Nova Science Publishers, Inc.   2014   ISBN:9781634631945, 9781634631631
Endometrial cancer is a female genital cancer that occurs frequently in Europe and the United States. Conventional therapy for endometrial cancer does not permit fertility preservation or have effects on advanced and recurrent cancers, and new pha...

Conference Activities & Talks

 
閉経後日本人女性の骨粗鬆症におけるメタボローム解析を用いた血漿バイオマーカーの検討
渡辺慶子, 飯田 美穂, 小林佑介, 冨永英一郎, 阪埜浩司, 武林亨, 青木大輔
第33回日本女性医学学会学術集会   3 Nov 2018   日本女性医学学会
地域住民におけるFatty liver indexとCAVIとの関連:鶴岡メタボロームコホート研究
平田あや、岡村智教、原田成、杉山大典、桑原和代、佐田みずき、栗原綾子、加藤寿寿華、飯田 美穂、武林亨
第77回日本公衆衛生学会総会   25 Oct 2018   日本公衆衛生学会
大規模疫学研究におけるCE-MS血液メタボロミクス測定値の信頼性: 鶴岡メタボロームコホート研究
原田成, 平山明由, 栗原綾子, 深井航太, 飯田 美穂, 加藤寿寿華, 杉山大典,桑原和代, 竹内文乃, 岡村智教, 冨田勝, 杉本昌弘, 曽我朋義, 武林亨
第28回日本疫学会学術総会   1 Feb 2018   日本疫学会
職域集団における自覚ストレス・対処方法(コーピング)と収縮期血圧の関連
深井航太,原田成,栗原綾子,飯田 美穂,加藤寿寿華,桑原和代,竹内文乃,杉山大典,岡村智教,武林亨
第90回日本産業衛生学会   11 May 2017   日本産業衛生学会
総身体活動量・座位時間と血漿メタボロームの関連:鶴岡メタボロームコホート
深井航太, 原田 成, 飯田 美穂, 栗原綾子, 竹内文乃, 桑原和代, 杉山大典, 岡村智教, 平山明由, 杉本昌弘, 曽我朋義, 冨田 勝, 武林亨
第27回日本疫学会学術総会   25 Jan 2017   日本疫学会

Teaching Experience

 

Works

 
みんなでなろう!こころのサポーター
飯田美穂   The Others   Nov 2018 - Today
みらい健康調査からみる健康長寿のヒケツ
The Others   Nov 2016 - Today
年を重ねるごとに輝く女性になるためのワンポイント
飯田美穂   The Others   Dec 2015 - Today
『鶴岡みらい健康調査』を知ろう~女性の健康づくりワンポイントアドバイス~
飯田美穂   The Others   Jun 2015 - Today

Research Grants & Projects

 
ステロイドホルモン・プロファイリングを用いた女性健康実現のための地域コホート研究
文部科学省: 科学研究費助成事業(科研費)
Project Year: Apr 2019 - Today    Investigator(s): 飯田美穂
近年、エイジングに伴う健康寿命延伸・QOL向上において、ステロイドホルモンが果たす役割の重要性が明らかになってきた。とくに高齢女性においては、更年期状態の把握以外に女性ホルモン濃度を測定する意義は乏しいとされてきたのに対し、閉経後の卵巣や副腎における性ホルモンやその前駆体の分泌が明らかとなり、これらの網羅的なプロファイルと認知機能低下、フレイルや動脈硬化性疾患、骨粗鬆症等との関連について検証する意義は大きい。
本研究では、高齢女性の健康状態やQOLに関連する代謝プロファイル・ステロイドホル...
メタボロミクス疫学による個別か女性予防医療研究:更年期障害の客観的評価指標の探索と疾患発症予測の検討
大和証券ヘルス財団: 平成30年度(第45回)調査研究助成
Project Year: Oct 2018 - Sep 2019    Investigator(s): 飯田美穂
女性活躍社会の実現は,多様性を尊重する世界の潮流となっている。人口減少社会を迎えるわが国においても,2020年までに指導的地位に女性が占める割合を30%程度とする目標が掲げられている.一方で,社会において指導的地位を担う可能性が高い40-50代女性において,更年期障害を有する女性の労働能力の低下は,更年期障害なしの場合の8.4倍にも及ぶことが示されている.更年期障害は,軽症のものも含めると全女性の半数以上が経験するが,エストロゲン分泌低下の直接的影響を受ける血管運動神経系症状(例:ほてり,...

Social Contribution

 
POLAウェルネスカフェ
[]  2018 - Today
鶴岡みらい健康づくり活動
[]  Apr 2014 - Today